Late-breaking results of ORIGIN Phase 2b trial supporting further evaluation of atacicept 150 mg as a potential disease-modifying treatment for IgAN will be presented at 60th European Renal ...

Square Enix has launched a brand new expansion for Stranger Of Paradise: Final Fantasy Origin called Trial Of The Dragon King. Developed by both Team Ninja and Koei Tecmo, this latest addition to the ...

BRISBANE, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for ...

Stranger of Paradise: Final Fantasy Origin‘s Trials of the Dragon King DLC will launch on July 20, Square Enix and Team NINJA have announced. Owners of the Stranger of Paradise Season Pass will ...

Jack, Ash, and Jed are the Warriors of Light in this new take on a Final Fantasy story. In the demo, the three are entering the Shrine of Chaos. In the original Final Fantasy on the NES, that’s where ...

Vera’s phase 2b ORIGIN data was underwhelming with lower than expected proteinuria reduction ~31% even at 9 months. We believe Atacicept’s commercial opportunity in IgAN is questionable due to the ...

Google will not make FLoC-based cohorts available for testing in countries where GDPR and the ePrivacy Directive are in effect. In other words, no FLoCs in Europe. At ...

It took a few days, but you can now actually play the Stranger of Paradise: Final Fantasy Origin demo. Unfortunately, since the moment it became available, no one could actually play it. While many ...

Today’s news: Origin Beta Trials Commence; Barb Expands Campaign Planning Tool; Pluto TV Partners with French AVOD Platform M6+ UK advertiser trade group ISBA yesterday announced the launch of Beta ...

BRISBANE, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative ...